These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38154510)
1. Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial. Rimner A; Gelblum DY; Wu AJ; Shepherd AF; Mueller B; Zhang S; Cuaron J; Shaverdian N; Flynn J; Fiasconaro M; Zhang Z; von Reibnitz D; Li H; McKnight D; McCune M; Gelb E; Gomez DR; Simone CB; Deasy JO; Yorke ED; Ng KK; Chaft JE Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):869-877. PubMed ID: 38154510 [TBL] [Abstract][Full Text] [Related]
2. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study. Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394 [TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study. Hepel JT; Leonard KL; Safran H; Ng T; Taber A; Khurshid H; Birnbaum A; ; Wazer DE; DiPetrillo T Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1021-1027. PubMed ID: 27745983 [TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277 [TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients. Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S Oncology; 2016; 91(4):194-204. PubMed ID: 27427761 [TBL] [Abstract][Full Text] [Related]
6. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study. Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369 [TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy. Woody NM; Stephans KL; Marwaha G; Djemil T; Videtic GM Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):325-31. PubMed ID: 25841625 [TBL] [Abstract][Full Text] [Related]
8. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer. Meng MB; Wang HH; Zaorsky NG; Sun BS; Zhu L; Song YC; Li FT; Dong Y; Wang JS; Chen HM; Yu XY; Yuan ZY Cancer Sci; 2019 Nov; 110(11):3553-3564. PubMed ID: 31464032 [TBL] [Abstract][Full Text] [Related]
9. Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer. Stephans KL; Woody NM; Reddy CA; Varley M; Magnelli A; Zhuang T; Qi P; Videtic GMM Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):462-469. PubMed ID: 29353658 [TBL] [Abstract][Full Text] [Related]
10. Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer. Courtney PT; Paravati AJ; Atwood TF; Raja N; Zimmerman CT; Fanta PT; Lowy AM; Simpson DR; Xu R; Murphy JD Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1003-1012. PubMed ID: 33571625 [TBL] [Abstract][Full Text] [Related]
11. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer. Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082 [TBL] [Abstract][Full Text] [Related]
13. Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer. Lee S; Song SY; Kim SS; Choi W; Je HU; Back GM; Cho B; Jeong SY; Choi EK Clin Lung Cancer; 2018 Mar; 19(2):e253-e261. PubMed ID: 29196082 [TBL] [Abstract][Full Text] [Related]
14. Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis. Verma V; Shostrom VK; Zhen W; Zhang M; Braunstein SE; Holland J; Hallemeier CL; Harkenrider MM; Iskhanian A; Jabbour SK; Attia A; Lee P; Wang K; Decker RH; McGarry RC; Simone CB Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):778-785. PubMed ID: 28244414 [TBL] [Abstract][Full Text] [Related]
15. A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer. Williams TM; Miller E; Welliver M; Brownstein J; Otterson G; Owen D; Haglund K; Shields P; Bertino E; Presley C; He K; Jacob NK; Walston S; Pan J; Yang X; Knopp M; Essan JK; McElroy J; Mo X; McElroy S; Carbone D; Bazan J Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):681-694. PubMed ID: 38387808 [TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases. Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687 [TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results. Levy A; Adebahr S; Hurkmans C; Ahmed M; Ahmad S; Guckenberger M; Geets X; Lievens Y; Lambrecht M; Pourel N; Lewitzki V; Konopa K; Franks K; Dziadziuszko R; McDonald F; Fortpied C; Clementel E; Fournier B; Rizzo S; Fink C; Riesterer O; Peulen H; Andratschke N; McWilliam A; Gkika E; Schimek-Jasch T; Grosu AL; Le Pechoux C; Faivre-Finn C; Nestle U J Thorac Oncol; 2024 Sep; 19(9):1297-1309. PubMed ID: 38788924 [TBL] [Abstract][Full Text] [Related]
18. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer. Temming S; Kocher M; Stoelben E; Hagmeyer L; Chang DH; Frank K; Hekmat K; Wolf J; Baus WW; Semrau R; Baues C; Marnitz S Strahlenther Onkol; 2018 Feb; 194(2):91-97. PubMed ID: 28812120 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiation Therapy for Biopsy-Proven Primary Non-Small-Cell Lung Cancer: Experience of Patients With Inoperable Cancer at a Single Brazilian Institution. Abreu CECV; Moraes FY; Miranda FA; Siqueira GSM; Gadia R; Haddad CK; Carvalho HA J Glob Oncol; 2018 Jul; 4():1-8. PubMed ID: 30085881 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study. Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]